Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma.
about
Virtual screening for potential inhibitors of Mcl-1 conformations sampled by normal modes, molecular dynamics, and nuclear magnetic resonance.High-dose thalidomide increases the risk of peripheral neuropathy in the treatment of ankylosing spondylitisAn update on the use of lenalidomide for the treatment of multiple myeloma.Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent
P2860
Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Thalidomide, clarithromycin, l ...... symptomatic multiple myeloma.
@en
type
label
Thalidomide, clarithromycin, l ...... symptomatic multiple myeloma.
@en
prefLabel
Thalidomide, clarithromycin, l ...... symptomatic multiple myeloma.
@en
P2093
P2860
P1433
P1476
Thalidomide, clarithromycin, l ...... symptomatic multiple myeloma.
@en
P2093
Adriana C Rossi
David Jayabalan
Faiza Zafar
Isaac A Bowman
Karen Pekle
Manan Shah
Melissa Rodriguez
Morton Coleman
Roger N Pearse
Ryann Quinn
P2860
P304
P356
10.3109/10428194.2014.896005
P577
2014-03-25T00:00:00Z